general
BMS Opdivo combo approved in US for hepatocellular carcinoma
GlobalData
The US Food and Drug Administration (FDA) has granted approval for Bristol Myers Squibbs (BMS) Opdivo (nivolumab) in combination with Yervoy (ipilimumab) as a first-line treatment for adults with unr ...[Continue Reading]
Pharmaceutical Technology
over 1 year ago
Recent News (General)
general
Italy withdraws support for Infantino, but Cannavaro backs FIFA chief
N/A
Italys football federation (FIGC) has withdrawn its support for embattled FIFA President Gianni Infantino over his failed attempt to sell off stakes in the World Cup. This decision is intended to cl ...[Continue Reading]

Al Jazeera English
1 day ago
general
The Large Hadron Collider Is Getting a Major Upgrade. But What Would Actually Surprise Physicists?
Gayoung Lee
As the old physics wisdom goes, to answer big questions, build big machines. To that idea, CERNs Large Hadron Collider (LHC) has really delivered on all fronts in its last 16 years of operations. As ...[Continue Reading]

Gizmodo.com
1 day ago
general
Theyve Been Screwed Over for 160 Years. Trump Is Screwing Them More.
Kali Holloway
White farmers insisted they dont want handouts, ever. An Iowa farmersWall Street Journalop-ed from late last year was headlined, AMERICAN FARMERS WANT FAIR TRADE, NOT HANDOUTS. They wont like it, J ...[Continue Reading]

The New Republic
1 day ago
general
Why Dolly Parton declined the Presidential Medal of Freedom 3 times
Nur Ibrahim
Claim: Singer Dolly Parton declined receiving the Presidential Medal of Freedom three times, twice from U.S. President Donald Trump and once from former President Joe Biden. On Aug. 25, 2026, Doll ...[Continue Reading]

Snopes.com
1 day ago
general
Workweek Raises $17 Million, Debuts B2B Newsletter Platform
Mark Stenberg
The business-to-business media company Workweek has raised an additional $17 million to fund the expansion of its newsletter platform, founder and chief executive Adam Ryan tells ADWEEK. The raise, ...[Continue Reading]

Adweek
1 day ago